|
"lu yen shen"的相關文件
顯示項目 66-109 / 109 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2010 |
O-6-Methylguanine-DNA Methyltransferase Expression and Prognostic Value in Brain Metastases of Lung Cancers
|
吳佩芳; 郭冠廷; 郭律廷; 林怡婷; 盧彥伸; 楊志新; 吳瑞美; 杜永光; 蔡瑞章; 曾漢民; 曾勝弘; 鄭安理; 林璟宏; WU, PEI-FANG; KUO, KUAN-TING; KUO, LU-TING; LIN, YI-TING; LU, YEN-SHEN; YANG, CHIH-HSIN; WU, RUEY-MEEI; TU, YONG-KWANG; TSAI, JUI-CHANG; TSENG, HAN-MIN; TSENG, SHENG-HONG; CHENG, ANN-LII; LIN, CHING-HUNG |
| 國立臺灣大學 |
2010 |
Combinations of Mtorc1 Inhibitor Rad001 with Gemcitabine and Paclitaxel for Treating Non-Hodgkin Lymphoma
|
江俊德; 葉培彥; 高明; 郭頌鑫; 徐志宏; 盧彥伸; 鄭安理; CHIANG, CHUN-TE; YEH, PEI-YEN; GAO, MING; KUO, SUNG-HSIN; HSU, CHIH-HUNG; LU, YEN-SHEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Fractionated Evaluation of Immunohistochemical Hormone Receptor Expression Enhances Prognostic Prediction in Breast Cancer Patients Treated with Tamoxifen as Adjuvant Therapy
|
林璟宏; 連晃駿; 胡賦强; 盧彥伸; 郭頌鑫; 游山林; 鄭安理; 黃俊升; LIN, CHING-HUNG; LIEN, HUANG-CHUN; HU, FU-CHANG; LU, YEN-SHEN; KUO, SUNG-HSIN; YOU, SAN-LIN; CHENG, ANN-LII; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2010 |
Management of Erbb2-Positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2010 |
Predictive and Prognostic Values of Tau and Ercc1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
|
邵幼雲; 郭冠廷; 胡賦强; 盧彥伸; 黃俊升; 廖肇裕; 許駿; 郭文宏; 張金堅; 林璟宏; 鄭安理; SHAO, YU-YUN; KUO, KUAN-TING; HU, FU-CHANG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; LIAU, JAO-YU; HSU, CHIUN; KUO, WEN-HONG; CHANG, KING-JEN; LIN, CHING -HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
The Prevalence and Assessment of Erbb2-Positive Breast Cancer in Asia: A Literature Survey
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2010 |
Vinorelbine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation
|
林柏翰; 盧彥伸; 林璟宏; 黃俊升; 鄭安理; 葉坤輝; LIN, PO-HAN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG; CHENG, ANN-LII; YEH, KUN-HUEI |
| 國立臺灣大學 |
2009 |
Induction of Bim Expression Contributes to the Antitumor Synergy between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal- Regulated Kinase Kinase Inhibitor Ci-1040 in Hepatocellular Carcinoma
|
歐大諒; 沈盈君; 梁嘉德; 劉俊揚; 俞松良; 盧彥伸; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; LIANG, JA-DER; LIOU, JUN-YANG; YU, SUNG-LIANG; LU, YEN-SHEN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Management of Her2-Positive Breast Cancer in Asia:Consensus Statement from the Asian Oncology Summit 2
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia
|
林璟宏; 盧彥伸; 黃俊升; 沈盈君; 郭頌鑫; 劉敏; 張金堅; 鄭安理; LIN, CHING-HUNG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; SHEN, YING-CHUN; KUO, SUNG-HSIN; LIU, JACQUELINE MING; CHANG, KING-JEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Poor Response to Systemic Chemotherapy in Metaplastic Carcinoma of Breast
|
盧彥伸; 黃俊升; 鄭安理; LU, YEN-SHEN; HUANG, CHIUN-SHENG; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Resource-Based Data Availability for Erbb2-Driven Breast Cancer in Asian Women: Experts' Opinion
|
盧彥伸; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Locoregional Therapy Improves Survival for Metastatic Breast Cancer Patients? Benefit Remains Questionable!
|
張端瑩; 林璟宏; 盧彥伸; CHANG, DWAN-YING; LIN, CHING-HUNG; LU, YEN-SHEN |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
The Cyp19 Ttta Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I-Ii and Operable Stage Iii Breast Cancers
|
黃俊升; 郭頌鑫; 連晃駿; 楊士儀; 游山林; 沈志陽; 林璟宏; 盧彥伸; 張金堅; HUANG, CHIUN-SHENG; KUO, SUNG-HSIN; LIEN, HUANG-CHUN; YANG, SHI-YI; YOU, SAN-LIN; SHEN, CHEN-YANG; LIN, CHING-HUNG; LU, YEN-SHEN; CHANG, KING-JEN |
| 國立臺灣大學 |
2008 |
Lesson of the Month - Differential Expression of Glucocorticoid Receptor in Carcinomas of the Human Digestive System
|
連晃駿; 盧彥伸; 孫家棟; 饒宇東; 張文靜; 鄭安理; LIEN, HUANG-CHUN; LU, YEN-SHEN; SHUN, CHIA-TUNG; YAO, YU-TUNG; CHANG, WEN-CHING; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Dose Variation and Regimen Modification of Adjuvant Chemotherapy in Daily Practice Affect Survival of Stage I-Ii and Operable Stage Iii Taiwanese Breast Cancer Patients
|
郭頌鑫; 連晃駿; 游山林; 盧彥伸; 林璟宏; 黃俊升; KUO, SUNG-HSIN; LIEN, HUANG-CHUN; YOU, SAN-LIN; LU, YEN-SHEN; LIN, CHING-HUNG; HUANG, CHIUN-SHENG |
| 國立臺灣大學 |
2008 |
Fty720 Induces Apoptosis in Hepatocellular Carcinoma Cells through Activation of Protein Kinase C Delta Signaling
|
洪瑞祥; 盧彥伸; 鄭安理; 陳慶士; HUNG, JUI-HSIANG; LU, YEN-SHEN; CHENG, ANN-LII; CHEN, CHING-SHIH |
| 國立臺灣大學 |
2008 |
Nf-Kappa B P50 Promotes Tumor Cell Invasion through Negative Regulation of Invasion Suppressor Gene Crmp-1 in Human Lung Adenocarcinoma Cells
|
高明; 葉培彥; 盧彥伸; 張文靜; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; CHANG, WEN-CHING; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Osu-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species- Related Autophagy in Hepatocellular Carcinoma
|
高明; 葉培彥; 盧彥伸; 徐志宏; 陳昆鋒; 陳慶士; 郭明良; 鄭安理; GAO, MING; YEH, PEI-YEN; LU, YEN-SHEN; HSU, CHIH-HUNG; CHEN, KUEN-FENG; CHEN, CHING-SHIH; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Down-Regulation of Phospho-Akt Is a Major Molecular Determinant of Bortezomib-Induced Apoptosis in Hepatocellular Carcinoma Cells
|
陳昆鋒; 葉培彥; 葉坤輝; 盧彥伸; 黃聖懿; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; YEH, KUN-HUEI; LU, YEN-SHEN; HUANG, SHANG-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
2007 |
Pneumatosis Coli after Etoposide Chemotherapy for Breast Cancer
|
施怡倫; 盧彥伸; 王秀伯; 劉高郎; SHIH, I-LUN; LU, YEN-SHEN; WANG, HSIU-PO; LIU, KAO-LANG |
| 國立臺灣大學 |
2007 |
A Phase Ii Trial of Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Patients with Chemotherapy-Pretreated Metastatic Breast Cancer
|
林家齊; 鄭安理; 徐志宏; 盧彥伸; 許駿; 葉坤輝; 吳貞瑤; 黃俊升; 楊志新; LIN, CHIA-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; LU, YEN-SHEN; HSU, CHIUN; YEH, KUN-HUEI; WU, CHEN-YAO; HUANG, CHIUN-SHENG; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Efficacy of a Novel Histone Deacetylase Inhibitor in Murine Models of Hepatocellular Carcinoma
|
盧彥伸; 林宗哲; 陳德蓉; 鄭安理; 陳慶士; LU, YEN-SHEN; LIN, ZHONG-ZHE; CHENG, TE-JUNG; CHENG, ANN-LII; CHEN, CHING-SHIH |
| 國立臺灣大學 |
2007 |
Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents That Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation
|
盧彥伸; 陳慶餘; 陳慶士; LU, YEN-SHEN; CHEN, CHING-YU; CHEN, CHING -SHIH |
| 國立臺灣大學 |
2007 |
Histone Deacetylase Inhibitors Sensitize Prostate Cancer Cells to Agents that Produce DNA Double-Strand Breaks by Targeting Ku70 Acetylation
|
Chen, Chang-Shi; Wang, Yu-Chieh; Yang, Hsiao-Ching; Huang, Po-Hsien; Kulp, Samuel K.; Yang, Chih-Cheng; Lu, Yen-Shen; Matsuyama, Shigemi; Chen, Ching-Yu; Chen, Ching-Shih |
| 國立臺灣大學 |
2006 |
皮質類固醇對癌細胞生長及藥物敏感性的影響及相關機轉之研究
|
盧彥伸; Lu, Yen-Shen |
| 國立臺灣大學 |
2006 |
PHASE I STUDY OF BIWEEKLY GEMCITABINE FOLLOWED BY OXALIPLATIN AND SIMPLIFIED 48-H INFUSION OF FLUOROURACIL/LEUCOVORIN FOR ADVANCED PANCREATIC CANCER
|
CHANG, HUI-JU; WANG, CHUAN-CHENG; CHENG, ANN-LII; HSU, CHIUN; LU, YEN-SHEN; CHANG, MING-CHU; LIN, JAW-TOWN; WANG, HSIU-PO; LIU, TSANG-WU; CHANG, JANG-YANG; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG; 張慧如; 王全正; 鄭安理; 許駿; 盧彥伸; 章明珠; 林肇堂; 王秀伯; 劉滄梧; 張俊彥; 彭汪嘉康; 陳立宗 |
| 國立臺灣大學 |
2006 |
Differential Expression of Glucocorticoid Receptor in Human Breast Tissues and Related Neoplasms
|
連晃駿; 盧彥伸; 鄭安理; 鄭永銘; 郭躍虹; 黃俊升; 張金堅; 饒宇東; LIEN, HUANG-CHUN; LU, YEN-SHEN; CHENG, ANN-LII; JENG, YUNG-MING; KUO, YAU-HUNG; HUANG, CHIUN-SHENG; CHANG, KING-JEN; YAO, YU-TUNG |
| 國立臺灣大學 |
2006 |
Glucocorticoids Enhance Cytotoxicity of Cisplatin Via Suppression of Nf-{ Kappa}B Activation in the Glucocorticoid Receptor-Rich Human Cervical Carcinoma Cell Line Siha
|
盧彥伸; 葉培彥; 莊雙恩; 高明; 郭明良; 鄭安理; LU, YEN-SHEN; YEH, PEI-YEN; CHUANG, SHUANG-EN; GAO, MING; KUO, MIN-LIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2006 |
Trends in Place of Death of Cancer Patients in Taiwan
|
林明慧; 盧彥伸; 陳曾基; 黃信彰; LIN, MIN-HEUY; LU, YEN-SHEN; CHEN, TZENG-JI; HWANG, SHINN-JANG |
| 國立臺灣大學 |
2005 |
Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer
|
葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII |
| 國立臺灣大學 |
2005 |
A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
|
盧彥伸; 楊志新; 許駿; LU, YEN-SHEN; YANG, CHIH-HSIN; HSU, CHIUN |
| 國立臺灣大學 |
2004-08 |
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram fr
|
Chang, Yeun-Chung; Huang, Chiun-Sheng; Liu, Yi-Jui; Chen, Jyh-Horng; Lu, Yen-Shen; Tseng, Wen-Yih I. |
| 國立臺灣大學 |
2004 |
Angiogenic Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy Evaluated with Parametric Histogram from Dynamic Contrast- Enhanced Mri
|
張允中; 黃俊升; 劉益瑞; 陳志宏; 盧彥伸; 曾文毅; CHANG, YEUN-CHUNG; HUANG, CHIUN-SHENG; LIU, YI-JUI; CHEN, JYH-HORNG; LU, YEN-SHEN; TSENG, WEN-YIH |
| 國立臺灣大學 |
2004 |
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI
|
Chang, Yeun-Chung; Huang, Chiun-Sheng; Liu, Yi-Jui; Chen, Jyh-Horng; Lu, Yen-Shen; Tseng, Wen-Yih I |
| 國立臺灣大學 |
2004 |
Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract.
|
許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Phase Ii Study of Combination Doxorubicin, Interferon-Alpha, and High- Dose Tamoxifen Treatment for Advanced Hepatocellular Carcinoma
|
盧彥伸; 許駿; 李啟誠; 郭頌鑫; 葉坤輝; 楊志新; 徐志宏; 吳貞瑤; 鄭安理; LU, YEN-SHEN; HSU, CHIUN; LI, CHI-CHENG; KUO, SUNG-HSIN; YEH, KUN-HUEI; YANG, CHIH-HSIN; HSU, CHIH-HUNG; WU, CHEN-YAO; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Recent Advances in the Management of Primary Breast Cancers
|
盧彥伸; 郭頌鑫; 黃俊升; LU, YEN-SHEN; KUO, SUNG-HSIN; HUANG, CHIUN-SHENG |
| 臺大學術典藏 |
2004 |
Angiogenic Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy Evaluated with Parametric Histogram from Dynamic Contrast- Enhanced Mri
|
Chang, Yeun-Chung;Huang, Chiun-Sheng;Liu, Yi-Jui;Chen, Jyh-Horng;Lu, Yen-Shen;Tseng, Wen-Yih陳志宏; 陳志宏; CHANG, YEUN-CHUNG; HUANG, CHIUN-SHENG; LIU, YI-JUI; CHEN, JYH-HORNG; LU, YEN-SHEN; TSENG, WEN-YIH |
| 國立臺灣大學 |
2003 |
High-Dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
葉坤輝; 盧彥伸; 蕭正祥; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSIAO, CHENG-HSIANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2002 |
A Phase Ii Study of Weekly Methotrexate, Cisplatin, and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin (Mp-Hdfl) in Patients with Metastatic and Recurrent Esophageal Cancer-Improving Toxicity Profile by Infusional Schedule and Double Biochem
|
徐志宏; 鄭安理; 許駿; 楊志新; 盧彥伸; 卜慶芳; 葉坤輝; HSU, CHIH-HUNG; CHENG, ANN-LII; HSU, CHIUN; YANG, CHIH-HSIN; LU, YEN-SHEN; BU, CHING-FANG; YEH, KUN-HUEI |
| 國立臺灣大學 |
2002 |
Basal Levels and Patterns of Anticancer Drug-Induced Activation of Nuclear Factor-κb (Nf-κb), and Its Attenuation by Tamoxifen, Dexamethasone, and Curcumin in Carcinoma Cells
|
莊雙恩; 葉培彥; 盧彥伸; 賴基銘; 廖昭銘; 高明; 鄭安理; CHUANG, SHUANG-EN; YEH, PEI-YEN; LU, YEN-SHEN; LAI, GI-MING; LIAO, CHAO-MING; GAO, MING; CHENG, ANN-LII |
顯示項目 66-109 / 109 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
